期刊
BJU INTERNATIONAL
卷 101, 期 11, 页码 1339-1342出版社
WILEY
DOI: 10.1111/j.1464-410X.2008.07506.x
关键词
clear cell carcinoma; platelet-derived growth factor inhibitor; progression-free survival; RCC; sunitinib; vascular endothelial growth factor inhibitor